Wageningen-based Scope Biosciences lands fresh capital to advance CRISPR-based molecular diagnostics platform
Scope Biosciences, a deep tech spin-off from Wageningen University & Research, has secured a follow-on investment from SHIFT Invest and ...
Tuesday, February 3, 2026
Tag: CRISPRbased
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.